GreenSignal Bio Pharma IPO

Please Share:: �� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��

��

-->

  »»  Issue Open: Nov 9, 2016 - Nov 11, 2016 
  »»  Issue Type: Book Built Issue IPO 
  »»  Issue Size: 
    ›  Offer for Sale of 14,579,560 Equity Shares of Rs 10 aggregating up to Rs [.] Cr 
  »»  Face Value: Rs 10 Per Equity Share 
  »»  Issue Price: Rs. 76 - Rs. 80 Per Equity Share 
  »»  Market Lot: 175 Shares 
  »»  Minimum Order Quantity: 175 Shares 
  »»  Listing At: BSE, NSE

Short Note about the Company:
GreenSignal Bio Pharma was incorporated as a Private Limited company in 2005 and became a Public Limited company in 2016. GSBPL was started with a vision of contribution to the well being of human beings by focusing on preventive health care products in particular vaccine. GSBPL is currently into production and supply of BCG Vaccine. After having stabilized in this space GSBPL wants to foray into other preventive and curative vaccine manufacturing.
GSBPL seeks to position itself as facilitator of R&D and augmenting the efforts of other players in this field (funded R&D and contract manufacturing)
It is one of the four companies worldwide who have been WHO-prequalified to supply the BCG vaccine to UNICEF.It has also secured a long term arrangement with UNICEF to supply the BCG vaccine.Vaccines manufactured by the GreenSignal Bio Pharma Limited are being used in 17 countries across the globe in their national immunization programs, saving millions of lives throughout the world.
Besides manufacturing, a Research and Development Laboratory for carrying out clinical trials and pilot projects in seed development, vaccine manufacturing etc., is being set-up at the TICEL Park, Chennai, Tamil Nadu, India.
Products in Pipeline :a) MMR: Measles ,b) Mumps,c) Rubella.d) TETANUS (TT),e) RABIES
Greensignal Bio Pharma plans to sell 14,579,560 equity shares through an offer for sale (OFS) in the IPO. The offer will represent 38% of its equity share capital.The company has received SEBI approval on September 9,2016. The shares will be offered through book-building process.*